# Trial to Evaluate the Efficacy and Safety of Nitazoxanide in the Treatment of Acute Uncomplicated Influenza

> **NCT02612922** · PHASE3 · COMPLETED · sponsor: **Romark Laboratories L.C.** · enrollment: 325 (actual)

## Conditions studied

- Influenza

## Interventions

- **DRUG:** Nitazoxanide
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02612922
- **Lead sponsor:** Romark Laboratories L.C.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-12
- **Primary completion:** 2016-09-04
- **Final completion:** 2016-09-04
- **Target enrollment:** 325 (ACTUAL)
- **Last updated:** 2018-04-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02612922

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02612922, "Trial to Evaluate the Efficacy and Safety of Nitazoxanide in the Treatment of Acute Uncomplicated Influenza". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT02612922. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*